Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study-Reference-Cited by-同舟云学术

Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: a controlled, multicenter, double-blind, parallel-group study

Published:2007-02 Issue:1 Volume:17 Page:1-9
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Hara Masako,Abe Tohru,Sugawara Sachiko,Mizushima Yutaka,Hoshi Keiko,Irimajiri Shoichiro,Hashimoto Hiroshi,Yoshino Shinichi,Matsui Nobuo,Nobunaga Masashi,Nakano Shigeyuki

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-006-0542-y

Reference13 articles.

1. Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells

2. Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted into SCID mice

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The SMILE study: Study of long-term methotrexate and iguratimod combination therapy in early rheumatoid arthritis;Chinese Medical Journal;2024-07-26

2. Significantly Delayed Development of Polyarthritis with Active Tenosynovitis after Possible Temporary Neutropenic Immune-Related Adverse Events Caused by Atezolizumab Treatment: A Novel Case Report;Case Reports in Oncological Medicine;2024-02-08

3. Iguratimod efficacy in palindromic rheumatism treatment;Immunity, Inflammation and Disease;2023-06

4. Efficacy and safety of Iguratimod as an add-on therapy for refractory lupus nephritis: A preliminary investigational study;Frontiers in Immunology;2023-03-08

5. Serum proteomics analysis of biomarkers for evaluating clinical response to MTX/IGU therapy in early rheumatoid arthritis;Molecular Immunology;2023-01